Cancer vaccines in the era of immunotherapy: from antigen delivery to immune ecosystem engineering

Adrien P. Mouren, Patrick A. Ott
Nature Reviews Clinical Oncology · Springer Nature · 2026-11-17 · DOI: 10.1038/s41571-026-01224-0

Abstract

Nature Reviews Clinical Oncology, Published online: 17 November 2026; doi:10.1038/s41571-026-01224-0 Therapeutic cancer vaccines reliably induce antitumour immune responses but evidence of translation into clinical benefit has largely been lacking. In this Review, the authors discuss key biological bottlenecks contributing to this disconnect as well as advances in antigen discovery, vaccine platform design, immune monitoring and computational biology that are enabling new therapeutic strategies with the potential for broad and durable clinical benefit, exploiting vaccines as modulators of the immune ecosystem rather than simply antigen-delivery systems.

Read at publisher →

Similar articles